Merkzettel Warenkorb
  • Produktbild: Controversies in the Management of Gynecological Cancers
  • Produktbild: Controversies in the Management of Gynecological Cancers
- 11%

Controversies in the Management of Gynecological Cancers

11% sparen

103,99 € UVP 117,69 €

inkl. gesetzl. MwSt., Versandkostenfrei

Lieferung nach Hause

Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

23.08.2016

Abbildungen

XV, 44 illus., 31 illus. in color., schwarz-weiss Illustrationen, farbige Illustrationen

Herausgeber

Jonathan A. Ledermann + weitere

Verlag

Springer London

Seitenzahl

349

Maße (L/B/H)

27,9/21/2 cm

Gewicht

896 g

Auflage

Softcover reprint of the original 1st ed. 2014

Sprache

Englisch

ISBN

978-1-4471-7170-6

Beschreibung

Rezension

From the book reviews:

“This book tackles current issues in the field of gynecological cancer. … The book is geared towards specialists in the field, although residents may find it useful. … The material is current and the data well done. This would be a good book for motivated trainees to bring to the table for discussions with attendings. Overall, the authors do a good job.” (Anthony Shanks, Doody’s Book Reviews, November, 2014)

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

23.08.2016

Abbildungen

XV, 44 illus., 31 illus. in color., schwarz-weiss Illustrationen, farbige Illustrationen

Herausgeber

Verlag

Springer London

Seitenzahl

349

Maße (L/B/H)

27,9/21/2 cm

Gewicht

896 g

Auflage

Softcover reprint of the original 1st ed. 2014

Sprache

Englisch

ISBN

978-1-4471-7170-6

Herstelleradresse

Springer-Verlag KG
Sachsenplatz 4-6
1201 Wien
AT

Email: GPSR Kontakt

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)
  • Produktbild: Controversies in the Management of Gynecological Cancers
  • Produktbild: Controversies in the Management of Gynecological Cancers
  • 1. Controversies in the Treatment of Women with Early Stage Epithelial Ovarian Cancer.- 2. Recurrent Ovarian Cancer: When to Treat and How to Assess.- 3. New Views of Ovarian Carcinoma Types: How will this Change Practice?.- 4. Lymphadenectomy in Endometrial Cancer: The Controversy Rages Unabated.- 5. What is the Role of Adjuvant Radiotherapy and Chemotherapy in Endometrial Cancer?.- 6. Chemotherapy and/or Targeted Therapies for Advanced Endometrial Cancer: Time to Rethink?.- 7. Is Cervix Cancer a Disappearing Disease? Impact of HPV Vaccination in Developed Countries.- 8. What is the Role of Cytotoxic Chemotherapy in Advanced Cervical Cancer?.- 9. Response as a Measure of Treatment Efficacy in Clinical Trials:  Should RECIST Be Abandoned?.- 10. What are the Treatment Options for Recurrent Ovarian Cancer?.- 11. How To Study Rare Gynaecological Tumours: Trials or Registries?.- 12. What is the Best Treatment Model for Gynaecological Cancers? Does Centralization Help?.- 13. When Should Surgery be Performed for the First-Line Treatment of Advanced Ovarian Cancer?.- 14. Does Intraperitoneal Therapy for Ovarian Cancer have a Future?.- 15. Maintenance Therapy for First-Line Treatment of Ovarian Cancer—Is this the Strategy for the Future?.- 16. What is the Value of Lymphadenectomy in Early Ovarian Cancer?.- 17. Sentinel Node Biopsy—Does it Help in the Management of Vulvar Cancer?.- 18. Controversies in the Management of Advanced Vulvar Cancer.- 19. Bowel Obstruction in Ovarian Cancer: To Operate or Not?.- 20. Early Cervical Cancer: Can Fertility be Safely Preserved?.- 21. What is the Role of PET/CT in Gynaecologic Cancers?.- 22. Do Intensity-Modulated Radiation, Image-Guided Radiation, and 3D Brachytherapy Significantly Advance Radiotherapeutic Management of Gynecologic Cancers?.- 23. What is the Place of Hormone Replacement Therapy in Ovarian, Endometrial, and Breast Cancer?.- 24. Familial Gynaecological Cancers: Whom to Screen and How to Manage?.- 25. Trial Design: Should Randomized Phase III Trials in Gynaecological Cancers be Abandoned?.- 26. How Should Early Gestational Trophoblastic Disease be Managed?.- 27. Should Every Woman with Gynaecologic Cancer Undergo Routine Screening for Psychological Distress and Sexual Dysfunction?.- 28. How Should Gynaecological Sarcomas be Managed?.- 29. What is the Future of Immunotherapy in Ovarian Cancer?.